Baltimore, MD – 2026 – Medifast (NYSE: MED), known for its science-backed, coach-guided lifestyle system, announced its financial results for the fourth quarter and full year ending December 31, 2025.
The company highlighted improvements in coach productivity, positive momentum in coach-led meetings, and a strong balance sheet as it executes its strategy to become a leading metabolic health company.
Â
Â
Â
Chairman and CEO, Dan Chard, said:
“In Q4, coach productivity turned positive year-over-year for the first time since 2022, historically a lead indicator of broader improvement. Coach-led meetings also increased significantly, showing our coach base is energized and focused on future opportunities.”
Dan Chard added:
“Our foundational work over the past two years has set a clear direction for growth. With plans in place, we are reinstating annual guidance and executing on our strategy to become a metabolic health company.”
Medifast’s financial position remains robust:
This strong capital base supports ongoing business transformation initiatives and strategic growth investments.
The company expects continued momentum from coach engagement and the execution of its metabolic health strategy to support future growth.
Medifast is a science-backed health and wellness company offering a coach-guided lifestyle system designed to address metabolic dysfunction. Its approach integrates:
The company’s Metabolic Synchronization™ program targets metabolic dysfunction, supporting fat burn, preserving lean mass, and improving body composition.
Get more information
There are no reviews yet. Be the first one to write one.
